Pliant Therapeutics, Inc. (PLRX) — Dilution Risk Analysis
Current Snapshot
Pliant Therapeutics, Inc. (PLRX) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: EFFECT 1, 8-K 1, S-3 1, 4 7.
| Form | Filed | Accession |
|---|---|---|
| EFFECT | 2026-04-06 | 9999999995-26-001103 |
| 8-K | 2026-03-30 | 0001746473-26-000046 |
| S-3 | 2026-03-30 | 0001193125-26-131933 |
| 4 | 2026-01-26 | 0001746473-26-000017 |
| 4 | 2026-01-26 | 0001746473-26-000018 |
| 4 | 2026-01-26 | 0001746473-26-000019 |
| 4 | 2026-01-26 | 0001746473-26-000020 |
| 4 | 2026-01-22 | 0001746473-26-000008 |
| 4 | 2026-01-22 | 0001746473-26-000009 |
| 4 | 2026-01-22 | 0001746473-26-000010 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $300,000,000 | Source |
| Cash runway | 14 months | Source |
| Three-year share count growth | 3.38% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 50/10) Source
- Cash Runway
- 14 months Source
- Shelf Registration Capacity
- $300,000,000 Source
- Share Count Growth (3-Year)
- 3.38% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.